Verified July 2026 · Cited to primary sources
Peptides marketed for skin, collagen, and anti-aging, graded by human evidence and legal status. The strongest skin evidence belongs to topical copper peptides (GHK-Cu), a legal cosmetic lane covered separately. The injectables here are far less proven.
Strongest human evidence in this category
Among injectable options, KPV and Epitalon are both Grade D, with no human efficacy trials. The evidence-backed skin route is topical GHK-Cu (Grade B for topical/cosmetic use), which is legal as a cosmetic and doesn't require injecting anything. We'd point most people there, not to a research injectable.
How we ranked these
We don't rank by popularity or by what we can sell you. Every peptide below is ordered by the same fixed rubric, and affiliate availability never moves a grade.
A historical FDA survey of compounded drugs found 31% failed standard potency testing. What is actually in the vial is a separate question from whether the compound works, and a rubric like this exists to keep the two apart. See the full A to F methodology →
Afamelanotide is a synthetic, more stable analog of alpha-melanocyte-stimulating hormone (alpha-MSH). It is a selective agonist at the melanocortin-1 receptor (MC1R) on melanocytes, driving synthesis of eumelanin in the skin independent of UV exposure. The extra eumelanin is photoprotective, which is the basis of its approved use.
Legitimate, best-in-class evidence for one narrow job: photoprotection in erythropoietic protoporphyria, where it is FDA-approved. For that use, Grade A. For the tanning use most people are actually asking about, you are buying an unapproved gray-market peptide with real melanoma-surveillance concerns and none of the approval-grade safety backing. Do not conflate the two.
See the evidence →A copper-binding tripeptide that stimulates collagen and elastin synthesis, activates fibroblasts, and supports wound repair. Its strongest evidence is topical, on skin.
GHK-Cu (copper peptides) is legal as a topical cosmetic, and for skin its human evidence is Grade B: real topical/cosmetic data, no drug approval. Injected GHK-Cu is a different, unapproved story (Grade D, no legal route). For skin or hair, the topical serum is the evidenced, legal choice. You don't need to inject anything.
See the evidence →Acetyl hexapeptide-8 mimics the N-terminal end of SNAP-25, a protein in the SNARE complex that muscle needs to release acetylcholine at the neuromuscular junction. By competing with SNAP-25, it is proposed to modestly dampen muscle contraction and so soften expression lines, a topical echo of what botulinum toxin does by injection. The big practical caveat is delivery: the peptide is large and hydrophilic, penetrates the stratum corneum poorly, and much of what is applied never reaches the nerve endings in the dermis. That penetration ceiling is the main reason topical effects stay modest.
Fine to use, just keep expectations honest. Argireline is a legal, safe, inexpensive cosmetic peptide with small placebo-controlled studies behind it, but the effect is a subtle softening of fine expression lines, held back by poor skin penetration. It is not topical Botox and will not match an injection. If you want it, treat it as a gentle add-on, not the centerpiece of a routine.
See the evidence →Matrixyl is palmitoyl-KTTKS: the pentapeptide KTTKS, a fragment of type I collagen, joined to a palmitic-acid tail that helps it cross the skin barrier. KTTKS acts as a matrikine, a signaling fragment that tells dermal fibroblasts to ramp up production of type I and type III collagen and fibronectin, essentially mimicking the feedback signal of collagen breakdown to prompt new matrix synthesis. The palmitoyl tail improves lipophilicity and skin penetration, which is why it tends to outperform non-lipidated peptides like argireline in head-to-head cosmetic studies. Unlike argireline it works by rebuilding matrix rather than relaxing muscle.
The one cosmetic peptide here worth a spot in a routine. Matrixyl has the best human evidence of the group: real split-face trials show a modest reduction in fine lines with retinoid-like benefit and none of the irritation. It will not remodel deep wrinkles or replace a retinoid, but as a gentle, well-tolerated add-on, especially for people who cannot tolerate retinoids, it is a defensible pick.
See the evidence →Anti-inflammatory tripeptide that suppresses NF-κB and pro-inflammatory signaling. Studied for gut and skin inflammation.
KPV is not FDA-approved and is not yet legal to compound. On July 23, 2026 the FDA's PCAC panel voted 8 to 6 (1 abstention) to recommend adding it to the 503A list for wound healing and inflammatory conditions, overriding the FDA's own scientists, but the FDA still decides and has not acted. Human evidence stays Grade D: cell and animal anti-inflammatory data only, no human trials.
See the evidence →Claimed to activate telomerase and regulate melatonin/circadian and pineal function. Marketed for longevity and anti-aging.
Epitalon is not FDA-approved and remains under FDA review. On July 24, 2026 the PCAC panel voted 7 to 5 (1 abstention) to recommend adding it to the 503A list for insomnia, but that is advisory and the FDA has not acted. Human evidence is Grade D: the longevity and anti-aging claims rest on small, low-quality Russian studies.
See the evidence →A non-selective melanocortin-receptor agonist that stimulates melanocytes to produce pigment (tanning), with off-target effects on appetite, sexual arousal and the cardiovascular system because it hits multiple melanocortin receptors.
Melanotan-2 (MT-2) is an unapproved "tanning" peptide with documented serious harms: melanoma and mole changes, priapism, nausea, blood-pressure changes and rhabdomyolysis have all been reported. Human evidence is Grade D and the safety flag is red. It is not the same as FDA-approved afamelanotide (Scenesse). There is no safe or legal way to buy it, and we do not recommend it.
See the evidence →| Peptide | Evidence | Legal & safety | Typical cost | Verdict | |
|---|---|---|---|---|---|
| Melanotan-1 (Afamelanotide / Scenesse) The one melanotan that is actually an FDA-approved drug. As Scenesse, afamelanotide is a prescription implant for a rare light-sensitivity disorder, not the gray-market tanning peptide people buy online. | Grade A | See evidenceSee the evidence for Melanotan-1 (Afamelanotide / Scenesse) | |||
| GHK-Cu The copper peptide behind decades of skincare. Real human topical/cosmetic evidence for skin, but injected versions are a different, unproven story. | Grade B | See evidenceSee the evidence for GHK-Cu | |||
| Argireline (Acetyl Hexapeptide-8) The peptide marketed as topical Botox. It does have small placebo-controlled human studies behind it, but the honest read is a modest softening of fine lines, nowhere near what an injection does. | Grade C | See evidenceSee the evidence for Argireline (Acetyl Hexapeptide-8) | |||
| Matrixyl (Palmitoyl Pentapeptide-4) The best-supported cosmetic peptide here. Real split-face human trials show a modest, retinol-adjacent reduction in fine lines, and it is gentle. Just do not expect a dramatic change. | Grade C | See evidenceSee the evidence for Matrixyl (Palmitoyl Pentapeptide-4) | |||
| KPV An anti-inflammatory tripeptide studied for gut and skin inflammation. Promising in cells and animals, untested in humans. | Grade D | See evidenceSee the evidence for KPV | |||
| Epitalon A longevity and anti-aging peptide built on small, low-quality Russian studies. The claims far outrun the evidence. | Grade D | See evidenceSee the evidence for Epitalon | |||
| Melanotan-2 (MT-2) An unapproved "tanning" peptide with documented serious harms. Melanoma and mole changes, priapism, nausea, and rhabdomyolysis have all been reported. This is a safety page, not a recommendation. | Grade D | See evidenceSee the evidence for Melanotan-2 (MT-2) |
Reading this table: Evidence is the A to F human-proof grade; Legal status and Safety are separate factual badges; Verdict is our honest one-line take. Affiliate availability never changes a grade. Full methodology.
FAQ
The strongest skin evidence belongs to topical copper peptides (GHK-Cu), which are legal as a cosmetic and don't require injecting anything. Among the injectable options here, KPV and Epitalon are both Grade D, with no human efficacy trials, so we'd point most people to a topical copper-peptide serum instead.
There is no reliable human evidence that Epitalon reverses aging or extends lifespan. The anti-aging and telomerase claims come from small, low-quality Russian studies and animal work, which lands it at Grade D on our scale.
The injectable skin peptides here (KPV, Epitalon) have little to no human safety data and no legal supervised US route. FDA testing has found many online and compounded peptides are mislabeled or contaminated, which is why we favor legal topical copper-peptide cosmetics for skin.
Read the evidence
Before you buy anything
Other goals
The monthly peptide evidence brief.
What the research and the FDA actually say, in one short email a month. Unsubscribe anytime.
No spam. We never sell your email. Editorial policy.